Hi Robin, Strange rumour indeed. BD Europe assured me they're still being manufactured and sales have even picked up a little lately. I find it hard to believe they won't "support" the instrument any time soon, given that they continue to support devices like the FACScan, which are relatively dinosaursian to the Calibur. I would expect new development of hardware add-ons and software updates to be few and far between from now on, but that's unrelated to hardware support. LSR II runs DiVA, so you probably won't have to face the "stalled software version" problem as soon as with, say, a Calibur. Also, in contrast to Vantages and Caliburs, there are no new BD models out there to replace the LSR II (Aria for Vantage, Canto for Calibur, resp.). Of course, trying to read the company's mind is no science. Try calling the reps or see the San Jose guys at the Bd stand at your next conference and just ask; it's probably at least as informative as my guesses. Hope this helps, Guy <http://www.ablynx.com> Next generation therapeutic antibodies Guy Hermans, PhD Project Leader Ablynx NV Technologiepark 4 B-9052 Zwijnaarde Belgium <mailto:guy.hermans@ablynx.com> guy.hermans@ablynx.com tel: fax: mobile: +32 (0)9 261 06 57 +32 (0)9 261 06 27 +32 (0)486 788 551 <https://www.plaxo.com/add_me?u=30065269879&v0=994426&k0=2009290972> Add me to your address book... <http://www.plaxo.com/signature> Want a signature like this? -----Original Message----- From: Stingley, Robin L [mailto:StingleyRobinL@uams.edu] Sent: Thursday, May 26, 2005 8:50 PM To: cyto-inbox Subject: Calibur, Canto or LSR II??? Hi all (again), A colleague is interested in purchasing a cytometer, and asked that I get opinions from this group. She is familiar with the FACSCalibur, but has been told that BD may discontinue them soon, and may not continue to support them. BD suggested either the FACSCanto or the LSR II, but neither of us is familiar with these instruments. I'm not sure how much money is available, but I think there is at least enough for a Calibur. I believe that I have seen previous messages here suggesting that the Canto still has issues that are being worked out, but I'm not sure about the LSR II. Has anyone else heard anything about the Calibur being discontinued? What would be the advantage of the LSR II (or the Canto) over the Calibur? Is there another instrument that she should be considering? Thanks, Robin Robin Stingley, Ph.D. Flow Cytometry Core Facility Department of Microbiology and Immunology University of Arkansas for Medical Sciences Slot 511, Rm B504 4301 West Markham Street Little Rock, Arkansas 72205 Phone: 501-686-6927 E-mail: StingleyRobinL@uams.edu <http://www.uams.edu/flowcytometry/> http://www.uams.edu/flowcytometry/
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:03:47 EST